Do the benefits of being a smoker hint at the existence of PD-1/PD-L1 sensitizers for patients on single-agent immunotherapy?
Crossref DOI link: https://doi.org/10.1136/jitc-2021-003191
Published Online: 2021-08-19
Published Print: 2021-08
Update policy: https://doi.org/10.1136/crossmarkpolicy
Zaleskis, Gintaras
Pasukoniene, Vita
Characiejus, Dainius
Urbonas, Vincas
License valid from 2021-08-19